Category Archives: Prognosis

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy. Author:  Anthony V. D’Amico Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment

Circulating Epithelial Tumor Cells and Tumor Spheres

Circulating Epithelial Tumor Cells (CETC) and Tumor Spheres. Discussion with Prof. Katharina Pachmann, Ph.D, M.D who is the medical Doctor in Jena University Hopital’s Department of Experimental Hematology and Oncology.  She is an expert on Circulating Epithelial Tumor Cells. The … Continue reading

Posted in Cancer Stem Cells, CETC, CTC, Prognosis, Prostate Cancer, Treatments for Prostate Cancer, Tumor Spheres | Leave a comment

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.

Predictors for response to intermittent androgen    deprivation (IAD) in prostate cancer cases with biochemical progression after surgery. Authors Sciarra A, et al. -Urol Oncol. 2013 Jul;31(5):607-14. Abstract presented and comments included by Dr. Israel Barken, the medical director of the … Continue reading

Posted in Castration Resistant Prostate Cancer, Intermittent Hormonal Blockade, Prognosis, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged | Leave a comment

PSA Response to Neoadjuvant Androgen Deprivation Therapy iIs a Strong Predictor of Survival

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

Posted in Hormonal Blockade, Prognosis, Prostate Cancer, PSA, Radiation Therapy, Survival prostate cancer, Treatments for Prostate Cancer | Tagged | Leave a comment

Cell Cycle Proliferation Score- Polaris

Posted in Biomarker, Prognosis, Treatments for Prostate Cancer | Tagged , , | Leave a comment

P 53- a prognostic test for prostate cancer.

Question of the week:  What is P53 and how is it used as a prognostic test? The related article of the week: P53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: … Continue reading

Posted in Checklist, Coaching, Markers, Prognosis, Prostate Cancer, Treatments for Prostate Cancer | Tagged | Leave a comment

Ask Dr. Barken – C-Reactive Protein

The following question is for the Ask Dr Barken Call In Show on Tuesday, Jan. 24th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:   What is C-Reactive Protein?  When should you use it as a marker? … Continue reading

Posted in Ask Dr. Barken, Diagnosis, Markers, Prognosis, Prostate Cancer, Survival prostate cancer, Treatments for Prostate Cancer | Tagged | Leave a comment